Status:
UNKNOWN
Pharmacogenomic Study of Androgenetic Alopecia
Lead Sponsor:
Taipei Medical University WanFang Hospital
Collaborating Sponsors:
Chang Gung Memorial Hospital
Conditions:
Androgenetic Alopecia
Eligibility:
All Genders
20-80 years
Brief Summary
Androgenic alopecia, the common form of hair loss is a highly heritable disorder of considerable social significance affecting around 40% of adult men and women. A variety of genetic and environmental...
Eligibility Criteria
Inclusion
- Willing to sign inform consent form
- Willing to received history taking by telephone or interview
- Diagnosed androgenetic alopecia by Hamilton-Norwood classification
- More than 20 year-old, both sex
Exclusion
- Ever had trauma over alopecia area
- Cancer, infection, or other systemic disease that might interfere diagnosis
- Unconfirmed diagnosis clinically or pathologically.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01227031
Start Date
October 1 2010
End Date
July 1 2011
Last Update
November 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University-Wan Fang Hospital
Taipei, Taiwan